Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
StateWatch: Summer 2018
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the services Genex provides.
StateWatch: Bill Review June/July 2018
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the bill review services Genex provides.
Managed vs. Unmanaged — A View Into All Pharmacy Transactions and the Differences Between Their Claim Populations
The next time you look up at the night sky and marvel at the countless stars consider this: For all the things you can see, there is far more you cannot. Most of our universe is filled with dark matter and dark energy. The stars, planets, and moons make up less than 5 percent of what’s out there. It’s a reminder that what isn’t evident can still be important. The same dichotomous view exists within the pharmacy space. There are many transactions we can see at a glance yet a still sizable number that are meaningful even though they’re not always readily apparent.
Mitchell Earns URAC Reaccreditation for Workers' Compensation Utilization Management
Reaccreditation Demonstrates Mitchell's Commitment to Quality Services
The Rise of the Electric Vehicle
As production and deliveries of the Tesla Model 3 continue to increase, more attention is being drawn to the growing trend towards vehicle electrification. Bloomberg New Energy Finance estimates that by the year 2040, 33% of the cars on the road worldwide will be electric vehicles (“EVs”).
Need-to-Know Tips for ADAAA Compliance